Oxymo Technologies. https://www.oxymotech.com/ , is a Canadian biotechnology company focused on the development of drugs for the treatment of Herpes Simplex Virus (HSV1/HSV2) infection. Herpes simplex virus (HSV) infection is a chronic and recurrent disease with significant clinical and socioeconomic burden. Unmet medical needs remain as current HSV therapies, both oral and topical provide modest clinical benefits.